Sasa Jarvis*

She | Her

Vancouver

778.328.1489

[email protected]

Expertise Cannabis Capital Markets & Securities Corporate Governance Mergers & Acquisitions Mining

Language(s) Spoken

English
Serbian
Bosnian

*Sasa Jarvis Law Corporation

Sasa Jarvis is a respected capital markets and securities lawyer. Her practice focuses primarily on corporate and securities law matters, where Sasa advises both private and public clients on a range of transactions. Her experience includes financings of public and private companies, initial public offerings, listings, mergers and acquisitions, and continuous disclosure obligations.

Representing clients in various industries, Sasa works extensively with clients in the mining and life sciences sectors. As part of her mining practice, Sasa advises public and private companies with respect to property option agreements, acquisitions of mineral properties, asset purchase and sale transactions, joint ventures, as well as technical disclosure.

Sasa’s life sciences practice includes providing advice to companies operating in highly regulated spaces, including cannabis and psychedelics, including on transactional and corporate compliance matters, going public transactions, raising funds, and continuing to comply with disclosure and other requirements. She has assisted clients in the cannabis space since the firm established its dedicated practice in 2016, and is a frequent writer and speaker on developments in Canadian law as they relate to psychedelic regulation.

Expertise

Industries

Practices

Representative Matters

Acted for HS GovTech Solutions Inc. in the acquisition of all of its issued and outstanding securities with a British Columbia subsidiary of a US private equity fund, by way of plan of arrangement, for total consideration of $33.3 million, 2023
Acted for Bright Minds Biosciences Inc. in connection with its prospectus and listing on the Canadian Securities Exchange, 2021
Acted for Bright Minds Biosciencess Inc. in an overnight marketed short form prospectus for gross proceeds of $25.9 million, March 2021
Acted for Turmalina Metals Corp. in an overnight marketed prospectus offering for gross proceeds of $8,500,000, February 2020
Acted for Turmalina Metals Corp. in connection with its prospectus and listing on the TSX Venture Exchange, 2019
Acted for Aurora Cannabis Inc. in connection with its acquisition of Whistler Medical Marijuana Corporation valued at $175,000,000.
Acted for Harvest One Cannabis Inc. (formerly Harvest One Capital Inc.) in its qualifying transaction involving the acquisition of 100% of the issued and outstanding shares of each of United Greeneries Holdings Ltd. from MMJ PhytoTech Limited and Satipharm AG from PhytoTechMedical (UK) Pty Ltd., a wholly subsidiary of MMJ PhytoTech Limited, and a related brokered $25,000,000 subscription receipt offering
Acts for various TSX Venture Exchange and Canadian Securities Exchange listed issuers in brokered and non-brokered debt and equity financings
Acts for companies completing going public transactions including reverse takeovers on the TSX Venture Exchange and Canadian Securities Exchange
Acts for Capital Pool Companies and businesses in completing “qualifying transactions” pursuant to the TSX Venture Exchange CPC program
Acted for VMS Ventures Inc. while Royal Nickel Corporation was purchasing it for a total consideration of $21.1 million, April 2016

Speaking Engagements

“Legislative Update”, Advanced Securities 2020 Series, Continuing Legal Education Society of British Columbia

June 2020

News

Media Mentions

“‘We can raise more money in the Middle East,’ says junior that left Canada for UAE,” The Northern Miner (July 2024)
“Dead Solaris deal has cash-strapped Canadian miners considering the door,” by Alisha Hiyate, The Northern Miner (June 27, 2024)
“Government rolls out faster permits, tax incentives to spur growth in critical mining“, Lexpert, (May 9, 2024)
“The new cannabis? – The drive towards allowing psychedelics such as magic mushrooms for some uses is gaining momentum“, by Luis Millàn, CBA/ABC National (September 27, 2021)

Directorships & Affiliations

Past Co-Chair of SOGIC-BC, a section of the Canadian Bar Association in British Columbia
Law Society of British Columbia

Education & Admissions

2015

Called to the British Columbia bar

2014

Juris Doctor with Business Law Concentration University of British Columbia

2011

BA, Political Science and Modern European StudiesUniversity of British Columbia

Publications

“The silence is deafening— Where is British Columbia going with mineral tenure reform following the Gitxaala decision?” Canadian Mining Journal, co-authored with Robin Junger, Cory Kent and Joan Young (March 2, 2024)
“The Energy Statutes Amendment Act – British Columbia’s New Regulatory Regime and New Liabilities for the Energy Industry,” co-authored with Ralph Cuervo-Lorens, Sean Ralph and Jordan Ghag, Energy Regulation Quarterly – Volume 11, Issue 3 (October 2023)
“Distributing securities to Canadian First Nations and the need to modernize NI45-106.” co-authored with Andrew Spencer, Cory Kent and Robin Junger (August 24, 2023)
“Foreign investment in critical minerals,” The Canadian Mining Journal (May 2023)
“Canada’s growing psychedelics industry has reason to pay attention to B.C. decriminalization decision,” The Globe and Mail (July 2, 2022)

Insights (31 Posts)View More

Canadian Miners Asking: Will Canada Remain a Competitive Jurisdiction for Mining Companies with Global Assets?

Mining companies are increasingly looking to move out of Canada to avoid application of the Government of Canada's restrictions on Chinese investment.

Jun 26, 2024

More Than Meets the Eye: The Legal Implications of British Columbia’s Agreement to Recognize Aboriginal Title Over Haida Gwaii

An analysis of legal implications related to the BC Government's agreement with the Haida Nation to recognize Aboriginal title over Haida Gwaii.

Apr 23, 2024

Cancel Print Job: CSA Finalizes Amendments to Allow Non-Investment Fund Reporting Issuers and Dealers to Deliver Prospectuses Electronically

Canadian Securities Administrators have adopted an optional "access equals delivery" model for prospectuses of reporting issuers that are not investment funds.

Mar 19, 2024

The Latest Risk to the BC Natural Resource Sector: Government Uses Little Known Law to Freeze Mining Rights Unless First Nations Consent

BC's government has issued unprecedented orders, to prohibit mining activity in certain areas, unless First Nations consent.

Mar 11, 2024

BC Government Consulting on New Law to Give Indigenous Groups Control over Crown Land Decisions

The Government of BC is seeking to amend the Land Act to provide decision making power over Crown land to Indigenous groups.

Jan 24, 2024

SCC Reference re Impact Assessment Act: A step in the right direction for the mining industry

On October 13, 2023, the SCC ruled that certain core provisions of Canada's Impact Assessment Act and its Physical Activities Regulations were unconstitutional.

Jan 9, 2024

New Listing: Amendments to CSE Form 2A Listing Statement

An overview of the amendments to CSE Form 2A Listing Statement, which replaced the previous prescriptive form with disclosure requirements as per Form 41-101F1.

Jun 27, 2023

Significant Amendments to CSE Policies come into force April 3, 2023

On March 30, 2023, the Canadian Securities Exchange announced that it is implementing comprehensive policy amendments effective April 3, 2023.

Mar 31, 2023

Recent Updates in the Canadian Psychedelics Landscape

Psychedelics have come to be viewed as a potential therapeutic tool by the general public and government. This bulletin summarizes recent Canadian developments.

Mar 14, 2023

The Energy Statutes Amendment Act – Expansion of Liability for Officers and Directors in Energy Sector

British Columbia’s Energy Statutes Amendment Act expands the potential liabilities for oil and gas activities to directors and officers.

Mar 10, 2023

Don’t put your LIFE on the line: US Securities Law Considerations for the Listed Issuer Financing Exemption

Considerations for issuers who intend to use the Listed Issuer Financing Exemption in connection with an offer and sale of securities in the United States.

Feb 9, 2023

The Energy Statutes Amendment Act – British Columbia Welcomes the Hydrogen Industry

British Columbia’s Energy Statutes Amendment Act makes sweeping changes to the regulation of energy in British Columbia.

Feb 1, 2023

Canadian Securities Administrators Comment on Disclosure Related to Mineral Projects and Technical Reports

On November 3, 2022, the Canadian Securities Administrators published Staff Notice 51-364 Continuous Disclosure Review Program Activities for 2022 and 2021.

Jan 24, 2023

Mind the (Non-)GAAP: Review of Financial Measures Disclosure Under NI 52-112

An overview of the common deficiencies flagged by the CSA with respect to issuers' compliance with disclosure requirements under NI 52-112 and CP 52-112.

Dec 23, 2022

Government of Alberta to Regulate Health Care Practitioners Administering Psychedelics

Alberta is implementing a new framework for regulating and licensing health care providers in connection with administering psychedelics.

Nov 9, 2022

Foreign Investment in Canada: Minerals are Critical and Annual Report Released

The government’s approach to reviewing foreign investment is evolving, with an increased focus on national security concerns.

Nov 7, 2022

2022 Starts on a High – Updates in the Psychedelics Industry and a Look Back at 2021

Recent amendments to the Special Access Program and a look back to 2021 on developments affecting the psychedelics industry.

Jan 11, 2022

Proposed Changes to the Promotional Activity Disclosure Requirements: Instrument 51-519

An overview of the proposed Instrument 51-519 from the BC Securities Commission on promotional activity disclosure requirements.

Jun 30, 2021

The Canadian Capital Market is Psyched: An Update on the Growing Wave in the Psychedelics Industry

This bulletin provides an overview of the regulations surrounding psychedelics in Canada and psychedelics companies in the Canadian capital markets.

May 12, 2021

Exemption for Four Patients Opens Door Further for Therapeutic Use of Psilocybin

A legal update on psychedelics: four Canadians with late stage cancer receive approval to use psilocybin to treat
their end-of-life distress.

Aug 19, 2020

Psychedelics and Canada’s Regulatory Landscape

A primer on the emerging psychedelics industry and how it fits into Canada's legal framework.

Jul 10, 2020

Stop the Presses: Printing of Disclosure Documents May Be a Thing of the Past

A summary of the proposal by CSA to adopt an "access equals delivery" model for disclosure documents.

Jan 22, 2020

CSA Notes Inadequate Disclosure of Financial Interest in Cannabis M&A

Securities regulators provided guidance regarding disclosure of financial interests and conflicts of interest in Cannabis transactions

Nov 15, 2019

The Next Phase of Canadian Cannabis: What to Expect in 2019 and Beyond

On June 14, 2019, Health Canada unveiled its Final Regulations for New Cannabis Products

Jun 21, 2019

Divergent Regulatory Approaches to Cryptocurrency Offerings: Developments in Canada, the United States, and China

Oct 9, 2017

Ontario Government to Grow LCBO: Recreational Cannabis to be sold at Government Stores

Sep 8, 2017

McMillan Advises on First Initial Coin Offering Granted Exemptive Relief by Canadian Securities Regulators

Sep 4, 2017

Canadian Securities Administrators Propose New Prospectus Exemption for Resale of Securities of a Foreign Issuer

Jul 10, 2017

Compliant at this Time: Canada’s Options Regarding its Treaty Obligations and the Legalization and Regulation of Non-Medical Cannabis

Compliant at this Time: Canada's Options Regarding its Treaty Obligations and the Legalization and Regulation of Non-Medical Cannabis

Jul 6, 2017

Prohibition to Go Up in Smoke: Government of Canada Introduces Legislation to Legalize and Regulate Non-Medical Access to Cannabis

Apr 17, 2017

Rights (offering) on the money: CSA announces changes to rights offering prospectus exemptions

Oct 7, 2015

Deals & Cases (5 Posts)

McMillan advised Bright Minds Bioscience on its USD$35 Million Non-Brokered Private Placement

Bright Minds Bioscience Inc. (CSE: DRUG, NASDAQ: DRUG) has closed a USD $35 million non-brokered private placement on November 4, 2024, issuing 1,612,902 common shares at USD $21.70 per share.

Nov 4, 2024

Emblem Corp. Completes Qualifying Transaction

Emblem Corp. was represented by a McMillan team led by Desmond Balakrishnan and included Barbara Collins, Arman Farahani, Mark Neighbor and Sasa Pudar (Capital Markets and M&A), Melanie Harmer (Litigation) assisting with court materials, and Michael Reid and Lindsay Dykstra (Business Law) assisting with due diligence.

Dec 21, 2016